File(s) under permanent embargo
P2.06-025 DREAM - A Phase 2 Trial of DuRvalumab with First Line chEmotherApy in Mesothelioma with a Safety Run In
journal contribution
posted on 2023-03-17, 05:06 authored by Anna Nowak, Peey-Sei Kok, Ann Livingstone, Willem Joost Lesterhuis, Sonia Yip, Mark Donoghoe, Wei-Sen Lam, Martin StocklerP2.06-025 DREAM - A Phase 2 Trial of DuRvalumab with First Line chEmotherApy in Mesothelioma with a Safety Run In
